Related Experiment Videos

[The guideline 'Cardiovascular risk management' is too simplified for elderly care]

Wouter de Ruijter1, Jacobijn Gussekloo

  • 1Leids Universitair Medisch Centrum, afd. Public Health en Eerstelijnsgeneeskunde, Leiden, the Netherlands. w.de_ruijter@lumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|September 7, 2012
PubMed

Insights

The addition of a 70-year-old category in cardiovascular risk management guidelines may lead to over-medicalization. A more age-differentiated approach is needed for older adults, considering vulnerability and alternative risk markers.

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • The 2011 Cardiovascular Risk Management guideline introduced a '70-year olds' age category.
  • This categorization results in most individuals aged 70+ exceeding a 20% 10-year cardiovascular risk threshold.
  • Consequently, many older adults become eligible for preventive medication, even after lifestyle interventions.

Purpose of the Study:

  • To critique the current age-based cardiovascular risk stratification for older adults.
  • To advocate for a more nuanced approach that accounts for age-related differences in vulnerability.
  • To explore alternative methods for assessing cardiovascular risk in the elderly.

Main Methods:

  • Commentary and critical analysis of existing cardiovascular risk management guidelines.
  • Discussion on the diminishing predictive power of traditional risk factors in advanced age.
  • Exploration of alternative risk assessment strategies for elderly populations.

Main Results:

  • The current '70-year olds' category risks the undue medicalization of a significant elderly population.
  • Classic cardiovascular risk factors have attenuated predictive value in older individuals.
  • A lack of age-differentiated approaches for older persons is identified.

Conclusions:

  • Decisions regarding preventive medication in older adults must incorporate individual vulnerability levels.
  • Alternative approaches like age-dependent thresholds and relative risk charts are proposed.
  • Further research into improved risk markers for very old individuals is essential.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...